NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.72

27 Aug
2026

-0.130

OPEN

$6.84

-1.90%

HIGH

$6.87

968,643

LOW

$6.70

TARGET
$7.36 9.5% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . IAG . MPL . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 38.4 151.3 xxx
DPS (cps) xxx 34.0 31.5 xxx
EPS Growth xxx - 6.5% 100.0% xxx
DPS Growth xxx 17.2% - 7.4% xxx
PE Ratio xxx N/A 4.5 xxx
Dividend Yield xxx N/A 4.7% xxx
Div Pay Ratio(%) xxx 88.5% 20.8% xxx

Dividend yield today if purchased 3 years ago: 4.17%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 5.04

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 05/03 - ex-div 13.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx38.4
DPS All xxxxxxxxxxxxxxx34.0
Sales/Revenue xxxxxxxxxxxxxxx3,817.3 M
Book Value Per Share xxxxxxxxxxxxxxx233.2
Net Operating Cash Flow xxxxxxxxxxxxxxx199.1 M
Net Profit Margin xxxxxxxxxxxxxxx4.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx16.58 %
Return on Invested Capital xxxxxxxxxxxxxxx13.56 %
Return on Assets xxxxxxxxxxxxxxx8.54 %
Return on Equity xxxxxxxxxxxxxxx16.58 %
Return on Total Capital xxxxxxxxxxxxxxx19.36 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx36.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx20 M
Long Term Debt xxxxxxxxxxxxxxx210 M
Total Debt xxxxxxxxxxxxxxx230 M
Goodwill - Gross xxxxxxxxxxxxxxx315 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx217 M
Price To Book Value xxxxxxxxxxxxxxx3.03

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx34.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.90 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx128 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,109 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

25/08/2026

3

Upgrade to Neutral from Underperform

$6.60

-1.79%

Softer Australian Residents Health Insurance (arhi) margins of 6.2% in FY26 for nib Holdings reflected higher-than-expected risk equalisation and Liability for Incurred Claims headwinds, Macquarie notes.

Nib expects $97m of net Travel proceeds, with $24m allocated to the 5c special dividend, $15-30m available for strategic investment and $43–58m for potential additional capital management. The ordinary payout target also increased to 65-75%.

Macquarie upgrades its recommendation to Neutral from Underperform based upon valuation. Target rises to $6.60 from $6.10.

FORECAST
Macquarie forecasts a full year FY27 dividend of 33.00 cents and EPS of 465.50 cents.
Macquarie forecasts a full year FY28 dividend of 36.00 cents and EPS of 50.20 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

25/08/2026

2

Overweight

$7.70

14.58%

Jarden maintains its Overweight recommendation for nib Holdings with an unchanged target price of $7.70 following a FY26 financial result featuring an underlying operating profit of $260.9m, which met expectations while reported net profit after tax reached $184.7m, driven by stronger investment income.

Underlying operating profit for the core Australian residents health insurance business fell -10% to $187.9m due to weaker-than-expected policyholder growth of 1.9% and a net margin deterioration to 6.2%.

Management declared a final dividend alongside an additional special dividend of 5.0c, signalling intentions for further capital management options following proceeds from nib Travel.

Guidance for FY27 group underlying operating profit was established at $265m to $285m, sitting slightly below market consensus at the midpoint.

The analyst notes that while short-term pressures on Australian residents health insurance gross margins and soft FY27 guidance may weigh on near-term trading, the stock remains well-supported by ongoing capital returns.
Access Extra Coverage Research History >

NHF STOCK CHART

FNArena News on NHF

1
Australian Broker Call *Extra* Edition – Aug 25, 2026

Aug 25 2026 - Daily Market Reports
2
FNArena Corporate Results Monitor – 24-08-2026

Aug 24 2026 - Australia
3
Rudi’s View: The August Earnings Test Is Approaching

Jul 29 2026 - Rudi's View
4
Rudi’s View: Small Cap Favourites, AI & More

Jul 16 2026 - Rudi's View
5
Next Week At A Glance – 15-19 Jun 2026

Jun 12 2026 - Weekly Reports

Latest Insurance News

1
The Rebuilding Of Tower

Apr 15 2026 - Small Caps
2
Treasure Chest: AI Risks To Insurance Brokers

Feb 11 2026 - Treasure Chest
3
ASIC Watch: Ai Governance Tax Hits Insurers

Dec 22 2025 - Australia
4
Insurance Sector’s AI Challenges Have Arrived

Nov 03 2025 - Australia
5
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
6
IAG Shares Breaking Out

Jan 21 2025 - Technicals
7
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
8
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
9
Steadfast’s Long March

Jul 02 2024 - Australia
10
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals